CareDx has developed innovative kit-based solutions for labs to enable better transplant surveillance. AlloSeq™ cfDNA (available outside of the United States), and AlloSeq HCT leverage the revolutionary improvements in cell-free DNA and chimerism testing respectively and drive early detection of relapse post-transplant.
AlloSeq HCT Logo

A turn-key testing kit that delivers highly sensitive chimerism testing with simple, informative results.

AlloSeq cfDNA Logo

Kit-based solution that enables precise measurement of dd-cfDNA through a blood test to drive better outcomes for transplant patients.